日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma

用于预测遗传异质性多发性骨髓瘤免疫治疗结果和免疫逃逸机制的临床前模型

Larrayoz, Marta; Garcia-Barchino, Maria J; Celay, Jon; Etxebeste, Amaia; Jimenez, Maddalen; Perez, Cristina; Ordoñez, Raquel; Cobaleda, Cesar; Botta, Cirino; Fresquet, Vicente; Roa, Sergio; Goicoechea, Ibai; Maia, Catarina; Lasaga, Miren; Chesi, Marta; Bergsagel, P Leif; Larrayoz, Maria J; Calasanz, Maria J; Campos-Sanchez, Elena; Martinez-Cano, Jorge; Panizo, Carlos; Rodriguez-Otero, Paula; Vicent, Silvestre; Roncador, Giovanna; Gonzalez, Patricia; Takahashi, Satoru; Katz, Samuel G; Walensky, Loren D; Ruppert, Shannon M; Lasater, Elisabeth A; Amann, Maria; Lozano, Teresa; Llopiz, Diana; Sarobe, Pablo; Lasarte, Juan J; Planell, Nuria; Gomez-Cabrero, David; Kudryashova, Olga; Kurilovich, Anna; Revuelta, Maria V; Cerchietti, Leandro; Agirre, Xabier; San Miguel, Jesus; Paiva, Bruno; Prosper, Felipe; Martinez-Climent, Jose A

Venetoclax combines synergistically with FLT3 inhibition to effectively target leukemic cells in FLT3-ITD+ acute myeloid leukemia models

维奈托克与FLT3抑制剂具有协同作用,可有效靶向FLT3-ITD阳性急性髓系白血病模型中的白血病细胞。

Singh Mali, Raghuveer; Zhang, Qi; DeFilippis, Rosa Anna; Cavazos, Antonio; Kuruvilla, Vinitha Mary; Raman, Jayant; Mody, Vidhi; Choo, Edna F; Dail, Monique; Shah, Neil P; Konopleva, Marina; Sampath, Deepak; Lasater, Elisabeth A

Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia

RAS通路激活介导的克隆选择导致急性髓系白血病对选择性FLT3抑制剂产生继发性临床耐药性

McMahon, Christine M; Ferng, Timothy; Canaani, Jonathan; Wang, Eunice S; Morrissette, Jennifer J D; Eastburn, Dennis J; Pellegrino, Maurizio; Durruthy-Durruthy, Robert; Watt, Christopher D; Asthana, Saurabh; Lasater, Elisabeth A; DeFilippis, RosaAnna; Peretz, Cheryl A C; McGary, Lisa H F; Deihimi, Safoora; Logan, Aaron C; Luger, Selina M; Shah, Neil P; Carroll, Martin; Smith, Catherine C; Perl, Alexander E

Overcoming myelosuppression due to synthetic lethal toxicity for FLT3-targeted acute myeloid leukemia therapy

克服FLT3靶向急性髓系白血病治疗中合成致死毒性引起的骨髓抑制

Warkentin, Alexander A; Lopez, Michael S; Lasater, Elisabeth A; Lin, Kimberly; He, Bai-Liang; Leung, Anskar Yh; Smith, Catherine C; Shah, Neil P; Shokat, Kevan M

Activity of ponatinib against clinically-relevant AC220-resistant kinase domain mutants of FLT3-ITD.

帕纳替尼对临床相关的 AC220 耐药 FLT3-ITD 激酶结构域突变体的活性

Smith Catherine C, Lasater Elisabeth A, Zhu Xiaotian, Lin Kimberly C, Stewart Whitney K, Damon Lauren E, Salerno Sara, Shah Neil P

Nf1+/- mice have increased neointima formation via hyperactivation of a Gleevec sensitive molecular pathway

Nf1+/- 小鼠由于格列卫敏感分子通路过度激活,导致新生内膜形成增加。

Lasater, Elisabeth A; Bessler, Waylan K; Mead, Laura E; Horn, Whitney E; Clapp, D Wade; Conway, Simon J; Ingram, David A; Li, Fang